Is serum albumin an independent predictor of survival in ovarian cancer?

Clinical Ovarian Cancer

Volumn 2, Issue 1, 2009, Pages 52-56

  Digant, Gupta ^a   Carolyn, A Lammersfeld ^a   Pankaj, G Vashi ^a   Sadie, Dahlk ^a   James, F Grutsch ^a   Christopher, G Lis ^a  

^a Office of Research   (United States)

Author keywords

Body mass index; Ca125; Malnutrition; Mortality; Prognosis

Indexed keywords

CA 125 ANTIGEN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; OVARY CANCER; PARAMETER; PREDICTION; RISK FACTOR;

EID: 77953444299     PISSN: 19414390     EISSN: 19414404     Source Type: Journal    
DOI: 10.3816/COC.2009.n.008     Document Type: Article

References (38)

1. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992- 1999. Gynecol Oncol 2005; 97:519-23.
2. Bandera EV. Nutritional factors in ovarian cancer prevention: what have we learned in the past 5 years? Nutr Cancer 2007; 59:142-51.
3. Chan JK, Cheung MK, Husain A, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006; 108:521-8.
4. Chan JK, Tian C, Monk BJ, et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer 2008; 112:2202-10.
5. Winter WE III, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007; 25:3621-7.
6. Chi DS, Liao JB, Leon LF, et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001; 82:532-7.
7. Hess LM, Barakat R, Tian C, et al. Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2007; 107:260-5.
8. Montazeri A, McEwen J, Gillis CR. Quality of life in patients with ovarian cancer: current state of research. Support Care Cancer 1996; 4:169-79. (Pubitemid 126482026)
9. von Meyenfeldt M. Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs 2005; 9(suppl 2):S35-8.
10. Laky B, Janda M, Bauer J, et al. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 2007; 61:642-6.
11. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491-7.
12. Laviano A, Meguid MM. Nutritional issues in cancer management. Nutrition 1996; 12:358-71.
13. Ovesen L, Hannibal J, Mortensen EL. The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 1993; 19:159-67.
14. Laky B, Janda M, Cleghorn G, et al. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 2008; 87:1678-85.
15. Gadducci A, Cosio S, Fanucchi A, et al. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Anticancer Res 2001; 21(4B):2941-7.
16. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56:779-85.
17. Gupta D, Lammersfeld CA, Vashi PG, et al. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 2005; 59:35-40.
18. Gupta D, Lammersfeld CA, Burrows JL, et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004; 80:1634-8. (Pubitemid 41103864)
19. McIntosh EN, Laurent LL. Nutritional assessment of the hospitalized patient. Am Fam Physician 1983; 27:169-75.
20. Boles JM, Garre MA, Youinou PY. Simple assessment of the nutritional status in the critically ill patient. Resuscitation 1984; 11:233-41.
21. Delmore G. Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 1997; 5:376-80.
22. Curtas S, Chapman G, Meguid MM. Evaluation of nutritional status. Nurs Clin North Am 1989; 24:301-13.
23. Slaviero KA, Read JA, Clarke SJ, et al. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003; 46:148-57.
24. Davies M. Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9(suppl 2):S64-S73.
25. Duguet A, Bachmann P, Lallemand Y, et al. Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment [article in French]. Bull Cancer 1999; 86:997-1016.
26. Santoso JT, Cannada T, O'Farrel B, et al. Subjective versus objective nutritional assessment study in women with gynecological cancer: a prospective cohort trial. Int J Gynecol Cancer 2004; 14:220-3.
27. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2:1434-6.
28. Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J 2007; 13:453-9.
29. Siddiqui A, Heinzerling J, Livingston EH, et al. Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 2007; 194:362-6.
30. Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol 2007; 14:381-9.
31. Boonpipattanapong T, Chewatanakornkul S. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas. J Clin Gastroenterol 2006; 40:592-5.
32. Cengiz O, Kocer B, Surmeli S, et al. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit 2006; 12:CR240-CR247.
33. Heys SD, Walker LG, Deehan DJ, et al. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 1998; 43:163-8.
34. Lis CG, Grutsch JF, Vashi PG, et al. Is serum albumin an independent predictor of survival in patients with breast cancer? JPEN J Parenter Enteral Nutr 2003; 27:10-5.
35. Seve P, Ray-Coquard I, Trillet-Lenoir V, et al. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer 2006; 107:2698-705.
36. Vigano A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000; 160:861-8. (Pubitemid 30165248)
37. Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 2000; 30:141-5.
38. Soreide JA, Lea OA, Kvinnsland S. Cytosol albumin content in operable breast cancer. Correlations to steroid hormone receptors, other prognostic factors and prognosis. Acta Oncol 1991; 30:797-802.